Roivant Sciences Ltd. · NASDAQ:ROIV

Torti Frank reported 7 trades in Roivant Sciences Ltd. shares (Form 4)

Traded Nov 10 to Nov 12, 2026 · Filed Nov 12, 2026

From Nov 10 to Nov 12, 2026, Torti Frank (President and Vant Chair) reported 7 trades in Roivant Sciences Ltd. shares at an average US$41.03 for US$48.3M, leaving 12,306,950 shares. Filed Nov 12, 2026 (Form 4).

Shares
1,176,143 shares
Price
US$41.03 average (US$40.36 to US$42.01)
Value
US$48.3M
Holding after
12,306,950 shares
Trading plan
No
Role
President and Vant Chair

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Nov 10, 2026Common SharesOther173,683US$40.4313,322,210Direct
Nov 10, 2026Common SharesOther218,369US$41.1313,103,841Direct
Nov 11, 2026Common SharesOther240,755US$41.6312,863,086Direct
Nov 11, 2026Common SharesOther151,293US$42.0112,711,793Direct
Nov 12, 2026Common SharesOther329,550US$40.3612,382,243Direct
Nov 12, 2026Common SharesOther62,493US$41.1312,319,750Direct
Nov 12, 2026Common SharesShares withheld for tax12,800US$41.8512,306,950Direct

Source

Download original · View original at SEC

Related